News from intrexon corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

May 26, 2015, 16:05 ET
Intrexon Corporation logo.

Intrexon to Present at the Jefferies 2015 Global Healthcare Conference

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that Gregory Frost, Ph.D., Senior Vice President and Head of...

May 11, 2015, 16:05 ET
Intrexon Corporation logo.

Intrexon Announces First Quarter 2015 Financial Results

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its first quarter results for 2015.  Business...

May 04, 2015, 08:00 ET
Intrexon Corporation logo

Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015

 Intrexon Corporation (NYSE: XON) today announced it will release first quarter 2015 financial results after the market closes on May 11,...

Apr 30, 2015, 08:00 ET
Intrexon Corporation logo.

Intrexon to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that Randal J. Kirk, Chairman and Chief Executive Officer,...

Apr 20, 2015, 08:00 ET
Intrexon Corporation logo

Intrexon Completes Acquisition of Okanagan Specialty Fruits

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has completed the acquisition of Okanagan Specialty Fruits...

Apr 15, 2015, 08:00 ET
Intrexon Corporation logo.

Driving Sustainable Agriculture through Improved Qualities in Eucalyptus and Poplar Trees

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, and FuturaGene Group, a wholly owned subsidiary of Suzano Papel e Celulose...

Apr 01, 2015, 16:05 ET
Mar 30, 2015, 08:00 ET
Intrexon Corporation logo. (PRNewsFoto/Intrexon Corporation)

Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, and Merck Serono, the biopharmaceutical business of Merck KGaA, Darmstadt,...

Mar 02, 2015, 16:05 ET
Intrexon Corporation logo.

Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its fourth quarter and full year results for 2014. ...

Feb 27, 2015, 16:30 ET
Intrexon Corporation logo.

Intrexon to Acquire Okanagan Specialty Fruits

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into an agreement to acquire Okanagan...

Feb 23, 2015, 07:00 ET

Intrexon to Announce Fourth Quarter and Full Year 2014 Financial Results on Monday, March 2, 2015

 Intrexon Corporation (NYSE: XON) today announced it will release fourth quarter and full year 2014 financial results after the market closes...

Feb 13, 2015, 07:15 ET
Intrexon Corporation logo

Living Biofactories in Your Prescription Bottle?

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into a definitive agreement to acquire...

Jan 27, 2015, 09:00 ET

Intrexon Announces Closing of $116 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today the closing of its previously announced public offering of...

Jan 26, 2015, 08:30 ET
Intrexon Corporation logo

Intrexon to Acquire Remaining Stake in Exemplar Genetics

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has launched a tender offer to acquire the remaining stake in...

Jan 21, 2015, 20:44 ET

Intrexon Prices Public Offering of Common Stock

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has priced its previously announced underwritten...

Jan 20, 2015, 16:02 ET
Intrexon Corporation logo.

Intrexon Announces Proposed Public Offering of Common Stock

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today it has commenced an underwritten public offering of up to $150...

Jan 13, 2015, 16:24 ET

Intrexon, ZIOPHARM, and MD Anderson in Exclusive CAR T Pact

Intrexon Corporation (NYSE: XON), a leader in synthetic biology and its oncology partner, ZIOPHARM Oncology (NASDAQ: ZIOP), today announced a broad...

Jan 06, 2015, 08:30 ET
Intrexon Corporation logo.

Intrexon to Present at the 2015 J.P. Morgan Healthcare Conference

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that Randal J. Kirk, Chairman and Chief Executive Officer of...

Dec 04, 2014, 09:00 ET

Intrexon Announces the Appointment of Peter Emtage, Ph.D., as Vice President, Synthetic Immunology

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Peter Emtage, Ph.D., as Vice President,...

Nov 13, 2014, 16:01 ET
Intrexon Corporation logo.

Intrexon Announces Third Quarter 2014 Financial Results

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its third quarter results for 2014.  Business...